Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200064926Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial of ciprofol and fentanyl in None (5 arms), sponsored by Shanghai Children's Medical Center. Primary endpoint: 90% effective dose of ciprofol. Planned start Oct 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200064926.